PROMETHEUS BIOSCIENCES INC (RXDX) Stock Balance Sheet
NASDAQ:RXDX - Nasdaq - US74349U1088 - Common Stock - Currency: USD
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 113.34M | 292.42M | 257.25M | 54.20M | 4.45M | |||
| Marketable Securities | 600.33M | 403.33M | N/A | N/A | N/A | |||
| Receivables | 0.00 | 1.03M | 1.08M | 1.09M | 0.00 | |||
| Other Current Assets | 12.73M | 11.37M | 7.05M | 2.17M | 33.08M | |||
| Total Current Assets | 726.40M | 708.15M | 265.38M | 57.46M | 37.53M | |||
| Non-Current Assets | ||||||||
| PPE Net | 31.04M | 31.65M | 1.45M | 450.00K | 320.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | 5.41M | |||
| Other Non-Current Assets | 971.00K | 971.00K | 971.00K | 1.73M | 7.22M | |||
| Total Non-Current Assets | 32.01M | 32.62M | 2.42M | 2.17M | 12.95M | |||
| TOTAL ASSETS | 758.41M | 740.77M | 267.80M | 59.63M | 50.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 5.68M | 4.70M | |||
| Accrued Expenses | 17.03M | 20.55M | 11.39M | 5.62M | 2.59M | |||
| Accounts Payable | 1.16M | 762.00K | 1.15M | 960.00K | 1.40M | |||
| Other Current Liabilities | 1.15M | 1.50M | 3.90M | 3.01M | 23.18M | |||
| Total Current Liabilities | 19.34M | 22.82M | 16.44M | 15.26M | 31.88M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 11.30M | 8.34M | |||
| Other Non-Current Liabilities | 41.46M | 41.99M | 16.20M | 4.60M | 3.50M | |||
| Total Non-Current Liabilities | 41.46M | 41.99M | 16.20M | 15.89M | 11.83M | |||
| TOTAL LIABILITIES | 60.80M | 64.81M | 32.65M | 31.15M | 43.71M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -371.97M | -331.09M | -189.34M | -99.15M | -37.45M | |||
| Additional Paid In Capital | 1.07B | 1.01B | 424.49M | 1.60M | 480.00K | |||
| Common Shares | 5.00K | 5.00K | 4.00K | 126.02M | 43.74M | |||
| Other Shareholders' Equity | -232.00K | -429.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 47.71M | 46.84M | 38.94M | 37.20M | 37.20M | |||
| Tangible Book Value per Share | 14.62 | 14.43 | 6.04 | -2.62 | -1.14 | |||
| Total Shareholders' Equity | 697.62M | 675.97M | 235.16M | 28.48M | 6.77M | |||
| TOTAL LIABILITIES AND EQUITY | 758.41M | 740.77M | 267.80M | 59.63M | 50.48M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.40 | 1.23 | |||
| Current Ratio | 37.56 | 31.04 | 16.14 | 3.77 | 1.18 | |||
| Return On Assets (ROA) | -19.85% | -19.14% | -33.68% | -62.28% | -58.87% | |||
| Return On Equity (ROE) | -21.58% | -20.97% | -38.36% | -130.41% | -439.00% | |||
All data in USD , ROIC based on taxRate of 0.21